US Market for Hemostasis Devices - 2016 (Forecasted to 2022) is a new market research publication announced by Reportstack. This segment includes only the analyzers and reagents used in core labs of hospitals and in independent commercial labs, without taking into consideration the point-of-care (POC) equipment. The U.S. hemostasis...
More...
